JP2014530831A5 - - Google Patents

Download PDF

Info

Publication number
JP2014530831A5
JP2014530831A5 JP2014536208A JP2014536208A JP2014530831A5 JP 2014530831 A5 JP2014530831 A5 JP 2014530831A5 JP 2014536208 A JP2014536208 A JP 2014536208A JP 2014536208 A JP2014536208 A JP 2014536208A JP 2014530831 A5 JP2014530831 A5 JP 2014530831A5
Authority
JP
Japan
Prior art keywords
compound
formula
phenyl
methyl
isoxazol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014536208A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014530831A (ja
JP5923174B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2012/070521 external-priority patent/WO2013057123A1/en
Publication of JP2014530831A publication Critical patent/JP2014530831A/ja
Publication of JP2014530831A5 publication Critical patent/JP2014530831A5/ja
Application granted granted Critical
Publication of JP5923174B2 publication Critical patent/JP5923174B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014536208A 2011-10-20 2012-10-17 イソオキサゾリル−メトキシ−ニコチン酸の調製方法 Active JP5923174B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP11185992.2 2011-10-20
EP11185992 2011-10-20
PCT/EP2012/070521 WO2013057123A1 (en) 2011-10-20 2012-10-17 Process for the preparation of isoxazolyl-methoxy-nicotinic acids

Publications (3)

Publication Number Publication Date
JP2014530831A JP2014530831A (ja) 2014-11-20
JP2014530831A5 true JP2014530831A5 (cg-RX-API-DMAC7.html) 2015-11-05
JP5923174B2 JP5923174B2 (ja) 2016-05-24

Family

ID=47019026

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014536208A Active JP5923174B2 (ja) 2011-10-20 2012-10-17 イソオキサゾリル−メトキシ−ニコチン酸の調製方法

Country Status (20)

Country Link
US (1) US8604062B2 (cg-RX-API-DMAC7.html)
EP (1) EP2768827B1 (cg-RX-API-DMAC7.html)
JP (1) JP5923174B2 (cg-RX-API-DMAC7.html)
KR (2) KR102262697B1 (cg-RX-API-DMAC7.html)
CN (1) CN103889978B (cg-RX-API-DMAC7.html)
AR (1) AR088358A1 (cg-RX-API-DMAC7.html)
AU (1) AU2012321095B2 (cg-RX-API-DMAC7.html)
BR (1) BR112014009266B1 (cg-RX-API-DMAC7.html)
CA (2) CA2850440C (cg-RX-API-DMAC7.html)
DK (1) DK2768827T3 (cg-RX-API-DMAC7.html)
ES (1) ES2613802T3 (cg-RX-API-DMAC7.html)
HU (1) HUE031276T2 (cg-RX-API-DMAC7.html)
IL (1) IL231645A (cg-RX-API-DMAC7.html)
MX (1) MX2014004688A (cg-RX-API-DMAC7.html)
MY (1) MY164880A (cg-RX-API-DMAC7.html)
PL (1) PL2768827T3 (cg-RX-API-DMAC7.html)
RU (1) RU2014118966A (cg-RX-API-DMAC7.html)
SG (1) SG11201401626UA (cg-RX-API-DMAC7.html)
SI (1) SI2768827T1 (cg-RX-API-DMAC7.html)
WO (1) WO2013057123A1 (cg-RX-API-DMAC7.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7403050B2 (ja) * 2017-08-28 2023-12-22 ユニバーシティ オブ メリーランド ボルチモア 気分障害のための新規ガンマアミノ酪酸型受容体モジュレーター
AU2019286312B2 (en) 2018-06-13 2023-08-17 F. Hoffmann-La Roche Ag New isoxazolyl ether derivatives as GABA A alpha5 PAM
HU231223B1 (hu) 2018-09-28 2022-01-28 Richter Gedeon Nyrt. GABAA A5 receptor modulátor hatású biciklusos vegyületek
US12649738B2 (en) 2020-03-26 2026-06-09 Richter Gedeon Nyrt. 1,3-dihydro-2H-pyrrolo[3,4-c]pyridine derivatives as GABAA α5 receptor modulators
TWI901650B (zh) 2020-03-26 2025-10-21 匈牙利商羅特格登公司 啶及吡啶并〔3,4-c〕嗒衍生物
GB202013765D0 (en) * 2020-09-02 2020-10-14 Gw Res Ltd Method of preparing cannabinoids
CN116854680A (zh) * 2022-03-28 2023-10-10 上海赛默罗生物科技有限公司 异噁唑-杂环类衍生物、药物组合物和用途
CN119265168B (zh) * 2024-11-05 2025-06-20 江南大学 一种新型腈水解酶及其在烟酸生物合成中的应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE315033T1 (de) 1998-08-07 2006-02-15 Chiron Corp Subtituierte isoxazole derivate als estrogen rezeptor modulatore
US6551804B2 (en) * 1999-07-12 2003-04-22 E. I. Du Pont De Nemours And Company Process for preparing 4-cyanopentanoic acid
WO2003099793A1 (en) 2002-05-24 2003-12-04 Takeda Pharmaceutical Company Limited 1,2-azole derivatives with hypoglycemic and hypolipidemic activity
GB0221443D0 (en) 2002-09-16 2002-10-23 Glaxo Group Ltd Pyridine derivates
UA82292C2 (uk) * 2004-04-14 2008-03-25 Пфайзер Продактс Инк. Спосіб стереоселективного біоперетворення аліфатичних динітрилів в ціанокарбонові кислоти (варіанти)
CA2564429A1 (en) 2004-05-14 2005-12-01 Irm Llc Compounds and compositions as ppar modulators
PL1802566T3 (pl) 2004-10-01 2009-05-29 Hoffmann La Roche Podstawione heksafluoroizopropanolem pochodne eteru
ATE485269T1 (de) 2005-06-27 2010-11-15 Bristol Myers Squibb Co C-verknüpfte zyklische antagonisten des p2y1- rezeptors mit eignung bei der behandlung thrombotischer leiden
JP2009508905A (ja) 2005-09-19 2009-03-05 エフ.ホフマン−ラ ロシュ アーゲー GABAAα5逆アゴニストとしてのイソオキサゾロ誘導体
CN101277952B (zh) 2005-10-11 2011-09-28 弗·哈夫曼-拉罗切有限公司 异*唑衍生物
RU2426731C2 (ru) 2005-12-23 2011-08-20 Ф. Хоффманн-Ля Рош Аг Производные арил-изоксазоло-4-ил-оксадиазола
US7618973B2 (en) 2007-12-04 2009-11-17 Hoffmann-La Roche Inc. Isoxazolo-pyrazine derivatives
US7943619B2 (en) 2007-12-04 2011-05-17 Hoffmann-La Roche Inc. Isoxazolo-pyridazine derivatives
JP5301557B2 (ja) * 2007-12-04 2013-09-25 エフ.ホフマン−ラ ロシュ アーゲー イソオキサゾロ−ピリジン誘導体
JP2012040448A (ja) * 2008-11-14 2012-03-01 Yasutaka Sakamoto マイクロバブル発生装置
US8222246B2 (en) 2009-04-02 2012-07-17 Hoffmann-La Roche Inc. Substituted isoxazoles
KR101354416B1 (ko) 2009-05-07 2014-02-19 에프. 호프만-라 로슈 아게 감마-아미노부티르산 조절제로서 이속사졸-피리딘 유도체

Similar Documents

Publication Publication Date Title
AU2004272338B2 (en) Pyrrol derivatives with antibacterial activity
RU2014118966A (ru) Способ получения изоксазолил-метокси-никотиновых кислот
KR101781663B1 (ko) 히스톤 데아세틸라제 효소를 억제하기 위한 화합물 및 이를 제조하는 방법
CN104583197B (zh) 新型双环吡啶衍生物
JP6012735B2 (ja) 新規ジヒドロキノリン−2−オン誘導体
JP2013528591A5 (cg-RX-API-DMAC7.html)
EP2073811A2 (en) Kinase inhibitors useful for the treatment of myleoproliferative diseases and other proliferative diseases
JP2013544840A5 (cg-RX-API-DMAC7.html)
AU2014229283A1 (en) 3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant IDH
US20060258672A1 (en) Multicyclic compounds and methods of their use
TW200902527A (en) 2-aminopyridine analogs as glucokinase activators
JP2018519323A5 (cg-RX-API-DMAC7.html)
CA2803842A1 (en) Nicotinamide derivative or salt thereof as syk-inhibitors
JP2010540443A5 (cg-RX-API-DMAC7.html)
TW200524872A (en) Process for preparation of pyridine derivatives
JP2008509955A5 (cg-RX-API-DMAC7.html)
CN104350040B (zh) 芳环化合物
NZ622214B2 (en) Process for the preparation of isoxazolyl-methoxy-nicotinic acids
HK1193610B (en) Process for the preparation of isoxazolyl-methoxy-nicotinic acids